SCHEMBL182255

SCHEMBL182255

CCOC(=O)C(=O)C1CCCC(=Cc2ccc(F)cc2)C1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
NPC1 O15118 4/20 0.46
MAPT P10636 5/20 0.46
CYP1A2 P05177 2/20 0.46
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
LMNA P02545 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HSD11B1 P28845 2/20 0.44
RAB9A P51151 3/20 0.41
EGFR P00533 1/20 0.40
STAT3 P40763 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
KDM4E B2RXH2 2/20 0.38
TP53 P04637 1/20 0.38
HPGD P15428 1/20 0.38
CCR6 P51684 2/20 0.37
HSP90AA1 P07900 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2719545 1.00 ALDH1A1 (0.46) ALDH1A1NPC1MAPTCYP1A2KMT2A
SCHEMBL182254 1.00 ALDH1A1 (0.46) ALDH1A1NPC1MAPTCYP1A2KMT2A
SCHEMBL13745233 0.97 NPC1 (0.48) ALDH1A1NPC1MAPTCYP1A2KMT2A
SCHEMBL176973 0.97 NPC1 (0.48) ALDH1A1NPC1MAPTCYP1A2KMT2A
SCHEMBL176972 0.97 NPC1 (0.48) ALDH1A1NPC1MAPTCYP1A2KMT2A
SCHEMBL394235 0.96 NPC1 (0.47) ALDH1A1NPC1MAPTCYP1A2KMT2A
SCHEMBL394236 0.96 NPC1 (0.47) ALDH1A1NPC1MAPTCYP1A2KMT2A
SCHEMBL645064 0.93 ALDH1A1 (0.48) ALDH1A1NPC1MAPTCYP1A2KMT2A
SCHEMBL645065 0.93 ALDH1A1 (0.48) ALDH1A1NPC1MAPTCYP1A2KMT2A
SCHEMBL2847136 0.81 MAPT (0.47) ALDH1A1MAPTCYP1A2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1735286-B1 TETRAHYDRO-INDAZOLE CANNABINOID MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-01-04 EP disclosed
US-20090099143-A1 TETRAHYDRO-INDAZOLE CANNABINOID MODULATORS LAGU BHARAT 2009-04-16 US disclosed
US-7452997-B2 Tetrahydro-indazole cannabinoid modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2008-11-18 US disclosed
EP-1931336-A1 TETRAHYDRO-INDAZOLYL CANNABINOID MODULATORS Janssen Pharmaceutica, N.V. (BE) 2008-06-18 EP disclosed
US-20070117857-A1 Substituted 3-amido-tetrahydro-indazolyl cannabinoid modulators JANSSEN PHARMACEUTICA, N.V. 2007-05-24 US disclosed
WO-2007038045-A1 TETRAHYDRO-INDAZOLYL CANNABINOID MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2007-04-05 WO disclosed
EP-1735286-A1 TETRAHYDRO-INDAZOLE CANNABINOID MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2006-12-27 EP disclosed
US-20050228034-A1 Tetrahydro-indazole cannabinoid modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2005-10-13 US disclosed
WO-2005095353-A1 TETRAHYDRO-INDAZOLE CANNABINOID MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2005-10-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070117857-A1 Substituted 3-amido-tetrahydro-indazolyl cannabinoid modulators CNR2, CNR1, GPR18 ALDH1A1 2561/4885NPC1 254/4885MAPT 1840/4885
US-20050228034-A1 Tetrahydro-indazole cannabinoid modulators CNR2, CNR1, GPR18 ALDH1A1 1597/4885NPC1 252/4885MAPT 1502/4885
US-20090099143-A1 TETRAHYDRO-INDAZOLE CANNABINOID MODULATORS CNR2, CNR1, GPR18 ALDH1A1 1597/4885NPC1 252/4885MAPT 1502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.